3SBIO
3SBio is a fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people.
3SBIO
Social Links:
Industry:
Biotechnology
Founded:
1993-01-01
Address:
Shenyang, Liaoning, China
Country:
China
Website Url:
http://www.3sbio.com
Total Employee:
501+
Status:
Active
Contact:
+862425386000
Total Funding:
15 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Font Awesome Nginx Euro ASP.NET Apple Mobile Web App Capable IIS
Similar Organizations
HanBio Therapeutics
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-09-03 | Therapure Biopharma | Therapure Biopharma acquired by 3sbio | 290 M USD |
| 2015-07-24 | Zhejiang Wansheng Pharmaceutical | Zhejiang Wansheng Pharmaceutical acquired by 3sbio | 85 M USD |
| 2015-01-26 | Sirton Pharmaceuticals | Sirton Pharmaceuticals acquired by 3sbio | N/A |
Investors List
Numab
Numab investment in Post-IPO Equity - 3sbio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-12-20 | GenSight Biologics | 3sbio investment in Post-IPO Debt - GenSight Biologics | 15 M EUR |
| 2019-12-12 | Numab | 3sbio investment in Series B - Numab | 22 M CHF |
| 2019-10-21 | Verseau Therapeutics | 3sbio investment in Venture Round - Verseau Therapeutics | 50 M USD |
| 2018-05-02 | Refuge Biotechnologies | 3sbio investment in Series B - Refuge Biotechnologies | 25 M USD |
Official Site Inspections
http://www.3sbio.com Semrush global rank: 8.36 M Semrush visits lastest month: 320
- Host name: 123.56.139.115
- IP address: 123.56.139.115
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
